Moreover, several published studies have designated p.Thr716Ala as deleterious, arguing that it abolishes binding to OLA1, a protein interacting in BRCA1-BARD1 complex, leading to the alteration of BARD1 tumor suppressor activity24–26. The gene discussed is BARD1; the disease is neoplasm.